U.S. Markets close in 1 hr 20 mins
  • S&P 500

    3,779.48
    -16.06 (-0.42%)
     
  • Dow 30

    30,910.89
    -80.63 (-0.26%)
     
  • Nasdaq

    13,053.37
    -59.27 (-0.45%)
     
  • Russell 2000

    2,132.26
    -23.09 (-1.07%)
     
  • Crude Oil

    52.37
    -1.20 (-2.24%)
     
  • Gold

    1,829.00
    -22.40 (-1.21%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2083
    -0.0081 (-0.6646%)
     
  • 10-Yr Bond

    1.0950
    -0.0340 (-3.01%)
     
  • Vix

    23.69
    +0.44 (+1.89%)
     
  • GBP/USD

    1.3590
    -0.0050 (-0.3683%)
     
  • USD/JPY

    103.8230
    -0.0190 (-0.0183%)
     
  • BTC-USD

    35,742.16
    -2,096.48 (-5.54%)
     
  • CMC Crypto 200

    686.37
    -48.77 (-6.63%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.08 (-0.62%)
     

Global Breast Biopsy Devices Market to Grow by $ 504.94 Million During 2020-2024 | Featuring Argon Medical Devices Inc., Becton, and Dickinson and Co. among others | Technavio

·4 min read

Technavio estimates the global breast biopsy devices market to grow by USD 504.94 million, progressing at a CAGR of about 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201230005388/en/

Technavio has announced its latest market research report titled Global Breast Biopsy Devices Market 2020-2024 (Graphic: Business Wire)

The market is driven by the growing prevalence of breast cancer cases. However, the presence of alternative non-invasive procedures might challenge growth.

Get a Free Sample Report Delivered Instantly to Know More

Breast Biopsy Devices Market: Product Landscape

Based on the product, the market saw maximum growth in the biopsy needles and systems segment in 2019. The segment is driven by the minimally invasive nature of the needle biopsy procedures. The market growth in the segment will be significant over the forecast period.

Breast Biopsy Devices Market: Geography Landscape

38% of the market’s growth originated from North America in 2019. Factors such as the high technology adoption among the healthcare sector, increasing healthcare expenditure, rising prevalence of breast cancer, and growing awareness among patients about mammograms to identify breast cancer incidence are driving the growth of the market in APAC.

The US is the key market for breast biopsy devices in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.

Develop Smart Strategies for Your Business: Get a Free Sample Report Now!

Major Three Breast Biopsy Devices Market Vendors:

Argon Medical Devices Inc.

Argon Medical Devices Inc. operates its business through segments such as Interventional Radiology, Vascular Surgery, Interventional Cardiology, Hematology Oncology, Urology, Mammography, and CT & Ultrasound. The company offers a wide range of breast biopsy needles such as Hawkins II breast localization needles, Accura breast localization needles - Kopans style, Hawkins III breast localization needles, Accura II breast localization needles - Sadowsky style, Hawkins I breast localization needles, and D wire breast localization needles.

Becton, Dickinson and Co.

Becton, Dickinson and Co. operates its business through segments such as BD Medical, BD Life Sciences, and BD Interventional. The company offers a wide range of breast biopsy systems such as VACORA breast biopsy system, ENCOR ENSPIRE breast biopsy system, and BD biopsy needles.

Carestream Health Inc.

Carestream Health Inc. operates its business through segments such as Radiography, Non-destructive testing, Contract Manufacturing, and Advanced Materials. The company offers DIRECTVIEW CR system. It is an affordable entry to digital mammography system and can be coupled with DIRECTVIEW CR mammography cassettes and EHR-M screens.

Give Your Business a Head Start for 2021: Download Our Free Sample Report

Related Reports on Consumer Discretionary Include:

Global Breast Cancer Liquid Biopsy Testing Devices Market – Global breast cancer liquid biopsy testing devices market is segmented by geography (Asia, Europe, North America, and ROW) and type (CTCs and circulating nucleic acids and extracellular vesicles). Click Here to Get an Exclusive Free Sample Report

Global Cervical Cancer Therapeutics Market – Global cervical cancer therapeutics market is segmented by type (drugs and vaccines) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts

What our reports offer:

  • Market share assessments for the regional and country-level segments

  • Strategic recommendations for the new entrants

  • Covers market data for 2019, 2020, until 2024

  • Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)

  • Strategic recommendations in key business segments based on the market estimations

  • Competitive landscaping mapping the key common trends

  • Company profiling with detailed strategies, financials, and recent developments

  • Supply chain trends mapping the latest technological advancements

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201230005388/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/